Back to DE D. E. Shaw & Co., Inc.
RARE30 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in ULTRAGENYX PHARMACEUTICAL IN
D. E. Shaw & Co., Inc. holds 1.7M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $57.8M as of 2026-Q2. The position was increased (+37.2% shares). RARE represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.
Current Value
$57.8M
Current Shares
1.7M
Total Value Change
+$43.8M
Total Shares Change
+1.4M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors